Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk - PubMed (original) (raw)
Clinical Trial
. 2004 Feb 18;43(4):678-83.
doi: 10.1016/j.jacc.2003.07.050.
Affiliations
- PMID: 14975482
- DOI: 10.1016/j.jacc.2003.07.050
Free article
Clinical Trial
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk
Hans K Meier-Ewert et al. J Am Coll Cardiol. 2004.
Free article
Abstract
Objectives: We sought to investigate the effects of sleep loss on high-sensitivity C-reactive protein (CRP) levels.
Background: Concentrations of high-sensitivity CRP are predictive of future cardiovascular morbidity. In epidemiologic studies, short sleep duration and sleep complaints have also been associated with increased cardiovascular morbidity. Two studies were undertaken to examine the effect of acute total and short-term partial sleep deprivation on concentrations of high-sensitivity CRP in healthy human subjects.
Methods: In Experiment 1, 10 healthy adult subjects stayed awake for 88 continuous hours. Samples of high-sensitivity CRP were collected every 90 min for 5 consecutive days, encompassing the vigil. In Experiment 2, 10 subjects were randomly assigned to either 8.2 h (control) or 4.2 h (partial sleep deprivation) of nighttime sleep for 10 consecutive days. Hourly samples of high-sensitivity CRP were taken during a baseline night and on day 10 of the study protocol.
Results: The CRP concentrations increased during both total and partial sleep deprivation conditions, but remained stable in the control condition. Systolic blood pressure increased across deprivation in Experiment 1, and heart rate increased in Experiment 2.
Conclusions: Both acute total and short-term partial sleep deprivation resulted in elevated high-sensitivity CRP concentrations, a stable marker of inflammation that has been shown to be predictive of cardiovascular morbidity. We propose that sleep loss may be one of the ways that inflammatory processes are activated and contribute to the association of sleep complaints, short sleep duration, and cardiovascular morbidity observed in epidemiologic surveys.
Comment in
- Does nondipping blood pressure profile contribute to vascular inflammation during sleep deprivation?
Desideri G, Croce G, Ferri C. Desideri G, et al. J Am Coll Cardiol. 2004 Oct 6;44(7):1529-30; author reply 1530-1. doi: 10.1016/j.jacc.2004.07.008. J Am Coll Cardiol. 2004. PMID: 15464344 No abstract available.
Similar articles
- [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS, Larsen AI. Munk PS, et al. Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1221-4. doi: 10.4045/tidsskr.08.0011. Tidsskr Nor Laegeforen. 2009. PMID: 19521445 Review. Norwegian. - Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress.
Hamer M, Williams ED, Vuononvirta R, Gibson EL, Steptoe A. Hamer M, et al. J Hypertens. 2006 Nov;24(11):2191-7. doi: 10.1097/01.hjh.0000249696.19360.be. J Hypertens. 2006. PMID: 17053540 Clinical Trial. - Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
Dupuy AM, Jaussent I, Lacroux A, Durant R, Cristol JP, Delcourt C. Dupuy AM, et al. Gerontology. 2007;53(6):329-39. doi: 10.1159/000103555. Epub 2007 Jun 5. Gerontology. 2007. PMID: 17551260 - Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome.
Santos AC, Lopes C, Guimarães JT, Barros H. Santos AC, et al. Int J Obes (Lond). 2005 Dec;29(12):1452-6. doi: 10.1038/sj.ijo.0803035. Int J Obes (Lond). 2005. PMID: 16077717 - C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield MB. Clearfield MB. J Am Osteopath Assoc. 2005 Sep;105(9):409-16. J Am Osteopath Assoc. 2005. PMID: 16239491 Review.
Cited by
- The Magnitude of Mortality from Ischemic Heart Disease Attributed to Occupational Factors in Korea - Attributable Fraction Estimation Using Meta-analysis.
Ha J, Kim SG, Paek D, Park J. Ha J, et al. Saf Health Work. 2011 Mar;2(1):70-82. doi: 10.5491/SHAW.2011.2.1.70. Epub 2011 Mar 31. Saf Health Work. 2011. PMID: 22953190 Free PMC article. - Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: a trial from the University of Rochester Cancer Center Community Clinical Oncology Program.
Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR. Palesh OG, et al. Sleep Med. 2012 Oct;13(9):1184-90. doi: 10.1016/j.sleep.2012.06.001. Epub 2012 Aug 2. Sleep Med. 2012. PMID: 22858235 Free PMC article. Clinical Trial. - Effects of Trazodone on Sleep: A Systematic Review and Meta-analysis.
Kokkali M, Pinioti E, Lappas AS, Christodoulou N, Samara MT. Kokkali M, et al. CNS Drugs. 2024 Oct;38(10):753-769. doi: 10.1007/s40263-024-01110-2. Epub 2024 Aug 9. CNS Drugs. 2024. PMID: 39123094 - Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.
Daulatzai MA. Daulatzai MA. Am J Neurodegener Dis. 2016 Mar 1;5(1):1-28. eCollection 2016. Am J Neurodegener Dis. 2016. PMID: 27073740 Free PMC article. Retracted. Review. - Sleep characteristics of self-reported long sleepers.
Patel SR, Blackwell T, Ancoli-Israel S, Stone KL; Osteoporotic Fractures in Men-MrOS Research Group. Patel SR, et al. Sleep. 2012 May 1;35(5):641-8. doi: 10.5665/sleep.1822. Sleep. 2012. PMID: 22547890 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous